Position in EYPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,492,176
+$3,922,735 QoQ
Shares Held
2,062,390
+4.0% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 188 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. EYPT ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in EYPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,492,176 | 2,062,390 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $25,569,441 | 1,983,665 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,701,434 | 1,899,367 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,709,249 | 1,524,526 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,981,171 | 1,592,048 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,634,221 | 1,593,030 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,464,819 | 1,538,902 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,580,456 | 1,199,056 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,981,505 | 1,032,357 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $17,210,606 | 832,637 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $15,770,656 | 682,417 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,279,244 | 535,575 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,373,246 | 502,672 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,415,557 | 481,482 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,584,908 | 452,831 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,564,815 | 450,672 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,552,809 | 451,437 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,189,726 | 427,138 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,300,634 | 351,359 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,586,074 | 344,153 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,989,085 | 332,490 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,495,856 | 147,230 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $384,015 | 58,361 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $270,294 | 519,797 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $395,045 | 519,797 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $911,446 | 893,575 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||